Michael Brady Lynch Firm Files First Nevada State Court Pradaxa Lawsuit
On October 18, 2012, The Michel Brady Lynch Firm, in conjunction with the Las Vegas firm of Edward M. Bernstein & Associates and the New Orleans firm Fishman, Haygood, Phelps, Walmsley, Willis & Swanson, filed the first Pradaxa bleeding lawsuit venue in Nevada state court. The lawsuit, filed on behalf of Robert W. Geske and
Read MoreMichael Brady Lynch Appointed to Pradaxa Plaintiff Steering Committee
By Order dated September 27, 2012, U.S. Chief Judge David Herndon has appointed Attorney Michael Brady Lynch, founder of The Michael Brady Lynch Firm in Orlando, FL, to serve on the Plaintiff’s Steering Committee (“PSC”) of In re Pradaxa Products Liability Litigation MDL #2385.
Attorney Michael Brady Lynch has been a leader in Pradaxa litigation nationwide. In his career, Attorney Lynch has represented over a thousand plaintiffs in MDL and state-coordinated mass tort claims, recovering over 200 million dollars in recoveries.
Read MorePradaxa Achieves Blockbuster Status
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm. It was with great fanfare that Pradaxa manufacturer Boehringer Ingelheim Pharmaceuticals announced last week that Pradaxa had achieved the status of a “blockbuster drug” (blockbuster status is defined as generating annual sales of $1 billion or more). Ironically, this announcement comes on the
Read MoreInjury Spotlight: Pradaxa Bleeding Dangers
Update: Pradaxa tied for first place as the drug most linked to adverse event reports filed with the FDA in 2011, showing that it is among the highest risk of all drug treatments, reported QuarterWatch, a non-profit drug monitoring organization. The FDA received reports of 3,781 serious, harmful events in 2011, as well as 542 deaths in the U.S. alone. Pradaxa surpassed all other drugs for negative reports involving hemorrhage, acute renal (kidney) failure and stroke. The growing crisis involving the blood thinner Pradaxa can be described in one word – scary…
Read More